Global Recombinant DNA Technology Market Research Report 2021
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Research Predicts that Recombinant DNA Technology Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Recombinant DNA Technology Market Overview:
Global Recombinant DNA Technology Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Recombinant DNA Technology involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Recombinant DNA Technology Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Recombinant DNA Technology market in 2020.
Global Recombinant DNA Technology Market Segmentation
By Type, Recombinant DNA Technology market has been segmented into:
by Product
by Types
By Application, Recombinant DNA Technology market has been segmented into:
Biotechnology and Pharmaceutical Companies
Academic & Government Research Institutes
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Recombinant DNA Technology market are:
Monsanto Company
Roche
Biogen
Amgen
Novartis
Eli Lilly and Company
GenScript
Pfizer Inc.
Novo Nordisk
Sanofi
Merck KGaA
Profacgen
Biocon
GlaxoSmithKline
Cibus
Horizon Discovery Group
New England Biolabs
1. Market Overview of Recombinant DNA Technology
1.1 Recombinant DNA Technology Market Overview
1.1.1 Recombinant DNA Technology Product Scope
1.1.2 Market Status and Outlook
1.2 Recombinant DNA Technology Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Recombinant DNA Technology Historic Market Size by Regions (2015-2020)
1.4 Recombinant DNA Technology Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Recombinant DNA Technology Sales Market by Type (2015-2026)
2.1 Global Recombinant DNA Technology Historic Market Size by Type (2015-2020)
2.2 Global Recombinant DNA Technology Forecasted Market Size by Type (2021-2026)
2.3 by Product
2.4 by Types
3. Covid-19 Impact Recombinant DNA Technology Sales Market by Application (2015-2026)
3.1 Global Recombinant DNA Technology Historic Market Size by Application (2015-2020)
3.2 Global Recombinant DNA Technology Forecasted Market Size by Application (2021-2026)
3.3 Biotechnology and Pharmaceutical Companies
3.4 Academic & Government Research Institutes
3.5 Others
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Recombinant DNA Technology Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Recombinant DNA Technology Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Recombinant DNA Technology Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Recombinant DNA Technology Business
5.1 Monsanto Company
5.1.1 Monsanto Company Company Profile
5.1.2 Monsanto Company Recombinant DNA Technology Product Specification
5.1.3 Monsanto Company Recombinant DNA Technology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Roche
5.2.1 Roche Company Profile
5.2.2 Roche Recombinant DNA Technology Product Specification
5.2.3 Roche Recombinant DNA Technology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Biogen
5.3.1 Biogen Company Profile
5.3.2 Biogen Recombinant DNA Technology Product Specification
5.3.3 Biogen Recombinant DNA Technology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 Amgen
5.4.1 Amgen Company Profile
5.4.2 Amgen Recombinant DNA Technology Product Specification
5.4.3 Amgen Recombinant DNA Technology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 Novartis
5.5.1 Novartis Company Profile
5.5.2 Novartis Recombinant DNA Technology Product Specification
5.5.3 Novartis Recombinant DNA Technology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Eli Lilly and Company
5.6.1 Eli Lilly and Company Company Profile
5.6.2 Eli Lilly and Company Recombinant DNA Technology Product Specification
5.6.3 Eli Lilly and Company Recombinant DNA Technology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 GenScript
5.7.1 GenScript Company Profile
5.7.2 GenScript Recombinant DNA Technology Product Specification
5.7.3 GenScript Recombinant DNA Technology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 Pfizer Inc.
5.8.1 Pfizer Inc. Company Profile
5.8.2 Pfizer Inc. Recombinant DNA Technology Product Specification
5.8.3 Pfizer Inc. Recombinant DNA Technology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 Novo Nordisk
5.9.1 Novo Nordisk Company Profile
5.9.2 Novo Nordisk Recombinant DNA Technology Product Specification
5.9.3 Novo Nordisk Recombinant DNA Technology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 Sanofi
5.10.1 Sanofi Company Profile
5.10.2 Sanofi Recombinant DNA Technology Product Specification
5.10.3 Sanofi Recombinant DNA Technology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.11 Merck KGaA
5.11.1 Merck KGaA Company Profile
5.11.2 Merck KGaA Recombinant DNA Technology Product Specification
5.11.3 Merck KGaA Recombinant DNA Technology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.12 Profacgen
5.12.1 Profacgen Company Profile
5.12.2 Profacgen Recombinant DNA Technology Product Specification
5.12.3 Profacgen Recombinant DNA Technology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.13 Biocon
5.13.1 Biocon Company Profile
5.13.2 Biocon Recombinant DNA Technology Product Specification
5.13.3 Biocon Recombinant DNA Technology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.14 GlaxoSmithKline
5.14.1 GlaxoSmithKline Company Profile
5.14.2 GlaxoSmithKline Recombinant DNA Technology Product Specification
5.14.3 GlaxoSmithKline Recombinant DNA Technology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.15 Cibus
5.15.1 Cibus Company Profile
5.15.2 Cibus Recombinant DNA Technology Product Specification
5.15.3 Cibus Recombinant DNA Technology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.16 Horizon Discovery Group
5.16.1 Horizon Discovery Group Company Profile
5.16.2 Horizon Discovery Group Recombinant DNA Technology Product Specification
5.16.3 Horizon Discovery Group Recombinant DNA Technology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.17 New England Biolabs
5.17.1 New England Biolabs Company Profile
5.17.2 New England Biolabs Recombinant DNA Technology Product Specification
5.17.3 New England Biolabs Recombinant DNA Technology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Recombinant DNA Technology Market Size (2015-2026)
6.2 North America Recombinant DNA Technology Key Players in North America (2015-2020)
6.3 North America Recombinant DNA Technology Market Size by Type (2015-2020)
6.4 North America Recombinant DNA Technology Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Recombinant DNA Technology Market Size (2015-2026)
7.2 East Asia Recombinant DNA Technology Key Players in North America (2015-2020)
7.3 East Asia Recombinant DNA Technology Market Size by Type (2015-2020)
7.4 East Asia Recombinant DNA Technology Market Size by Application (2015-2020)
8. Europe
8.1 Europe Recombinant DNA Technology Market Size (2015-2026)
8.2 Europe Recombinant DNA Technology Key Players in North America (2015-2020)
8.3 Europe Recombinant DNA Technology Market Size by Type (2015-2020)
8.4 Europe Recombinant DNA Technology Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Recombinant DNA Technology Market Size (2015-2026)
9.2 South Asia Recombinant DNA Technology Key Players in North America (2015-2020)
9.3 South Asia Recombinant DNA Technology Market Size by Type (2015-2020)
9.4 South Asia Recombinant DNA Technology Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Recombinant DNA Technology Market Size (2015-2026)
10.2 Southeast Asia Recombinant DNA Technology Key Players in North America (2015-2020)
10.3 Southeast Asia Recombinant DNA Technology Market Size by Type (2015-2020)
10.4 Southeast Asia Recombinant DNA Technology Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Recombinant DNA Technology Market Size (2015-2026)
11.2 Middle East Recombinant DNA Technology Key Players in North America (2015-2020)
11.3 Middle East Recombinant DNA Technology Market Size by Type (2015-2020)
11.4 Middle East Recombinant DNA Technology Market Size by Application (2015-2020)
12. Africa
12.1 Africa Recombinant DNA Technology Market Size (2015-2026)
12.2 Africa Recombinant DNA Technology Key Players in North America (2015-2020)
12.3 Africa Recombinant DNA Technology Market Size by Type (2015-2020)
12.4 Africa Recombinant DNA Technology Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Recombinant DNA Technology Market Size (2015-2026)
13.2 Oceania Recombinant DNA Technology Key Players in North America (2015-2020)
13.3 Oceania Recombinant DNA Technology Market Size by Type (2015-2020)
13.4 Oceania Recombinant DNA Technology Market Size by Application (2015-2020)
14. South America
14.1 South America Recombinant DNA Technology Market Size (2015-2026)
14.2 South America Recombinant DNA Technology Key Players in North America (2015-2020)
14.3 South America Recombinant DNA Technology Market Size by Type (2015-2020)
14.4 South America Recombinant DNA Technology Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Recombinant DNA Technology Market Size (2015-2026)
15.2 Rest of the World Recombinant DNA Technology Key Players in North America (2015-2020)
15.3 Rest of the World Recombinant DNA Technology Market Size by Type (2015-2020)
15.4 Rest of the World Recombinant DNA Technology Market Size by Application (2015-2020)
16 Recombinant DNA Technology Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Research Methodology:
Recombinant DNA Technology Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|